Walleye Trading LLC Athenex, Inc. Transaction History

Walleye Trading LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$2.97 - $4.84 $27,683 - $45,113	-9,321 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$3.71 - $5.13 $189 - $261	-51 Reduced 0.54%	9,321 $43,000
Q1 2021 May 17, 2021	BUY	$4.08 - $14.75 $38,237 - $138,237	9,372 New	9,372 $40,000
Q4 2020 Feb 16, 2021	SELL	$11.06 - $14.01 $6,038 - $7,649	-546 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$10.26 - $14.55 $5,601 - $7,944	546 New	546 $7,000

1.46M

Ticker ATNX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 156,790,000
Market Cap $1.57M
Description
Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

Stay updated on Walleye Trading LLC with notifications on news.